APONTIS PHARMA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.52 EUR | +1.67% |
|
-3.84% | +79.37% |
| Apr. 05 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
| Mar. 28 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Apontis Pharma AG
b39cce8344464fcc4affb18fb50.enXVrix_pYcV-y-6e5Meg63YNKRWpKH0QJ-thlSLiFo.GQSH52ZKlPVzkV-JOvop58-hU9MS-_SzGOnH_wvI_BwjTITKahLL7EafXA~922339c1b2c8dc66c502be1fdc0f8613
Upcoming events on Apontis Pharma AG
Past events on Apontis Pharma AG
| 2024-05-16 | Annual General Meeting |
| 2024-05-12 | German Spring Conference |
| 2024-05-08 05:00 am | Q1 2024 Earnings Call |
| 2024-05-08 01:30 am | Q1 2024 Earnings Release |
| 2024-04-09 | Roadshow - Montega |
| 2024-04-03 | Investor Meeting |
| 2024-03-28 06:30 am | Q4 2023 Earnings Call |
| 2024-03-28 02:30 am | Q4 2023 Earnings Release |
| 2023-11-09 04:00 am | Q3 2023 Earnings Call |
| 2023-11-09 01:30 am | Q3 2023 Earnings Release |
| 2023-09-03 | German Fall Conference |
| 2023-08-22 | Hamburg Investor Day |
| 2023-08-10 03:00 am | Q2 2023 Earnings Call |
| 2023-08-10 01:30 am | Q2 2023 Earnings Release |
| 2023-07-09 | Extraordinary Shareholders Meeting |
| 2023-05-14 | Equity Forum Spring Conference |
| 2023-05-12 04:00 am | Annual General Meeting |
| 2023-05-09 03:00 am | Q1 2023 Earnings Call |
| 2023-05-09 01:30 am | Q1 2023 Earnings Release |
| 2023-04-03 | Investor Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 39,2 | 51,2 51,2 -0.03% | 55,7 55,6 0.17% | 37,0 35,9 3.06% | 51,3 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | 4,86 5,90 -17.59% | 5,57 5,63 -1.14% | -13,3 -13,8 3.54% | 3,80 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | 3,12 2,45 27.18% | 3,88 3,87 0.24% | -15,2 -15,8 4.03% | 1,80 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 0,25 1,75 -85.81% | 3,83 3,73 2.53% | -14,8 -16,0 7.02% | 1,80 |
|
Net income Million EUR | Released Forecast Spread | -1,18 | -0,75 1,35 -155.2% | 2,69 2,77 -2.82% | -11,3 -14,7 23.28% | 1,30 |
|
EPS EUR | Released Forecast Spread | 0,00 | -0,09 0,17 -153.33% | 0,32 0,32 -2.17% | -1,33 -1,74 23.57% | 0,16 |
| Announcement Date | 29/04/21 | 30/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2022 S1 | 2022 Q3 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 24,0 | 10,5 | 9,80 | ||
|
EBITDA Million EUR | Released Forecast Spread | 1,40 | 0,90 | |||
|
EBIT Million EUR | Released Forecast Spread | 1,20 | ||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 2,39 | ||||
|
Net income Million EUR | Released Forecast Spread | -2,20 | 2,35 | |||
| Announcement Date | 11/08/21 | 11/08/22 | - | - | - |
More events
Past sector events for Apontis Pharma AG
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APPH Stock
- Calendar Apontis Pharma AG
